French hearing ahead for faulty heart valve patients
This article was originally published in Clinica
The French association representing patients who received the faulty Telectronics heart valves is now hoping to that there will be a first hearing in Lyon before the end of the year to begin compensation proceedings for French patients. This is after seven years of struggle.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.